3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
8
Breast Neoplasms
8
Vitamin D Deficiency
7
Polycystic Ovary Syndrome
4
Leukemia, Lymphocytic, Chronic, B-Cell
3
Warts
2
Rectal Neoplasms
2
Osteoporosis
2
Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Stroke
1
Spinal Cord Injuries
1
Seizures
1
Psoriasis
1
Prostate Adenocarcinoma
1
Polyps
1
Pathologic Processes
1
Pain
1
Ovarian Neoplasms
1
Osteoarthritis
1
Obesity
1
Neoplasms by Site
1
Myelodysplastic Syndromes
1
Meningitis
1
Melanoma, Cutaneous Malignant
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Interventions
Sorafenib
52
pembrolizumab
26
Nivolumab
20
Bevacizumab
19
Radiosurgery
17
Doxorubicin
12
atezolizumab
9
Erlotinib Hydrochloride
9
lenvatinib
8
cabozantinib
7
Magnetic Resonance Spectroscopy
7
tremelimumab
6
durvalumab
6
Ramucirumab
6
Radiofrequency Ablation
6
Cisplatin
6
Sunitinib
5
tislelizumab
4
regorafenib
4
Oxaliplatin
4
Leucovorin
4
Ipilimumab
4
Fluorouracil
4
Everolimus
4
Capecitabine
4
nintedanib
3
fluoromisonidazole
3
carotuximab
3
bavituximab
3
Tomography, X-Ray Computed
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma, Hepatocellular
×
Cholecalciferol
×
Clear all
No trials found.